Open Access

Dystrophins and dystrobrevins

Genome Biology20012:reviews3006.1

https://doi.org/10.1186/gb-2001-2-4-reviews3006

Published: 5 April 2001

Summary

A unique arrangement of domains makes up the common region of two otherwise very different proteins - long, elegant dystrophin, and its rather dumpy distant cousin, dystrobrevin. The two work in concert, forming the core of a large membrane-bound complex in all metazoa. Like many proteins, dystrophin and dystrobrevin have diversified in the vertebrate clade, as have their binding partners, yielding specialized complexes tailored to different cellular and subcellular locations. Disruption of several components of the complex is known to result in syndromes that include progressive myopathy, sometimes combined with cognitive defects; the best known of these is Duchenne muscular dystrophy. Despite a wealth of biochemical, cell biological and genetic information, the precise role of dystrophins, dystrobrevins and their collaborators remains unclear.

Gene organization and evolutionary history

Classification

The paradigm of the family is human dystrophin, originally identified [1] through its deficiency in the lethal neuromuscular disorder Duchenne muscular dystrophy (DMD) [2,3]. In addition to dystrophin, vertebrates possess two closely related proteins - utrophin [4] and dystrophin-related protein 2 (DRP2) [5]. A single common ancestor of these three proteins is present in all invertebrate metazoans hitherto examined [6]; I shall refer to these generically as the dystrophins.

A protein distantly related to the carboxy-terminal part of the dystrophins was isolated from the electric organ of the electric ray Torpedo [7]. Now known as dystrobrevin, it is present as a single protein in invertebrates and two closely related proteins (α- and β-dystrobrevin) in vertebrates [8,9,10]. The dystrophins and dystrobrevins bind to each other via a homotypic coiled-coil interaction [11].

Although dystrophin and dystrobrevin-like proteins in non-metazoans have yet to be identified, a very remotely related protein has been described [12]; discontinuous actin hexagon (DAH) is an actin-binding membrane-associated phosphoprotein required for cellularization of the embryonic syncytium in Drosophila. The sheer degree of divergence of DAH from the presumed last common ancestor of dystrophin and dystrobrevin hints at a more ancient history and broader functional scope for these proteins.

Gene organization

At more than 2.4 megabases (Mb), with some introns several hundred kilobases (kb) in length, the human dystrophin gene is the largest ever characterized (see Table 1). The reason for the evolutionary maintenance of this large gene size is unclear, but it appears that other vertebrate dystrophin and utrophin genes are similarly colossal (the human utrophin gene has been estimated at 900 kb). Even the Drosophila dystrophin-like gene [13], at 130 kb, is large by this organism's standards.
Table 1

Properties of dystrophin and dystrobrevin genes

Protein

Gene size (kb)

Number of exons

Protein size

Map position

GenBank accession number

Reference

Homo sapiens Dystrophin

>2,400

79

3,685*

Xp21.2

M18533

[1]

H. sapiens Utrophin

~900

~78

3,433

6q24

X69086

[4]

H. sapiens DRP2

45

24

957

Xq22.1

U42519

[5]

Drosophila melanogaster Dys

130

32

3,124

3R 92A6-92A7

AF277386

[6,13]

C. elegans Dys-1

31

46

3,674

I:9.17-9.42

AJ012469

[39]

H. sapiens α-Dystrobrevin

>180

24

686*

18q12.1-p12.2

U46744

[8]

H. sapiens β-Dystrobrevin

>130

21

627

2p23-p22

AF022728

[9,10]

D. melanogaster Dyb

5

5

614

2R 49A5-49A7

AF277387

[13]

C. elegans Dyb-1

6

9

590

I:16.1

AJ131742

[52]

*Subject to alternative splicing and/or alternative promoter use. Dys, dystrophin.

The genes are also complex - the human dystrophin gene itself has 79 coding exons [14], a substantial amount of alternative splicing [15,16], and at least seven tissue-specific promoters, which generate a range of transcripts encoding proteins differing in the length and/or sequence of their amino termini. For example, use of a promoter in intron 29 in the retina results in expression of a protein corresponding to the carboxy-terminal 260 kDa of dystrophin; DMD mutations that disrupt this isoform result in congenital stationary night blindness (in addition to the skeletal myopathy caused by all DMD mutations). The utrophin gene has an almost identical intron-exon organization to that of dystrophin, whereas the DRP2 gene shares most aspects of its structure with exons 55-79 of the dystrophin gene. Although the gene structure of vertebrate dystrobrevins strongly resembles that of exons 64-77 of the human dystrophin gene, the organization of the invertebrate dystrophin and dystrobrevin genes is surprisingly idiosyncratic; the Drosophila dystrophin gene has less than half as many exons as its human counterpart, including a mammoth 3.5 kb coding exon.

Evolutionary history

Analysis of known dystrophin and dystrobrevin sequences yields a clear phylogeny for the protein family that is consistent with the accepted phylogeny of the animals bearing them [6,17]. From this we can fairly confidently infer the following evolutionary history (Figure 1). A distant (non-metazoan) ancestor had a single dystrophin/dystrobrevin protein, which probably functioned as a homodimer. We cannot yet tell whether the long amino-terminal extension of the dystrophins is an ancestral or derived trait. At some point before the last common ancestor of metazoans, a duplication gave rise to separate dystrophin and dystrobrevin genes, their protein products now forming a heterodimer of more specialized components. This is the situation in most extant metazoans, including the protochordate amphioxus [6]. In vertebrates, however, a series of further duplications occurred, as had been documented for many other genes [18]. The first of these gave rise to DRP2 (via a partial duplication) and a common ancestor of dystrophin and utrophin, and to α- and β-dystrobrevin. The second resulted in the separate dystrophin and utrophin genes. All vertebrates appear to have this final complement of three dystrophin-like proteins and two dystrobrevins. Interestingly, the syntrophins, which bind to dystrophins and dystrobrevins (see below), have a tree of identical topology [13].
Figure 1

Phylogenetic tree of the dystrophin/dystrobrevin family, inferred from a tree constructed using sequences of the cysteine-rich and carboxy-terminal domains of human and fruit fly proteins [6]. Branching to form paralogs is shown vertically and branching to form orthologs (speciation) is shown perpendicular to the page.

Characteristic structural features

These large, multi-domain proteins are traditionally subdivided into the following distinct sections (Figure 2).
Figure 2

Structures of the vertebrate dystrophin/dystrobrevin family compiled from the crystal structures of the dystrophin actin-binding domain, two spectrin repeats from α-actinin, and the cysteine-rich region of dystrophin (PDB numbers 1dxx, 1quu and 1eg4, respectively). Actin binding region: cyan, CH1; green, CH2. 'Cysteine-rich' region: green, WW domain; red, orange, cyan, and purple, EF hands. Carboxy-terminal region: yellow, syntrophin-binding segment; red, leucine heptads.

The actin-binding domain (residues 1-220 of human dystrophin)

The amino-terminal 220 amino acids of dystrophin, utrophin, and the invertebrate dystrophins show clear homology to the well known actin-binding regions of the spectrin and α-actinin families, each of which comprises two tandem calponin-homology domains. The amino-terminal domains of dystrophin and utrophin have been shown by a variety of methods to bind to filamentous actin with binding affinities in the low micromolar range and a marked preference for non-muscle forms of actin. The tertiary structures of actin-binding domains from both proteins have been established (Figure 2), and their position on actin filaments has been modeled from electron micrographs of decorated fibers [19,20].

The rod domain (residues 338-3,055 of human dystrophin)

More than 70% of the length of dystrophin, utrophin and the invertebrate dystrophins consists of a rather weakly repeated motif akin to a loose version of the spectrin repeat [21]. These approximately 110-amino-acid motifs are assumed, like their spectrin counterparts, to form antiparallel three-helix bundles (as is modeled in Figure 2). The considerable variability in length and sequence suggests, however, that such a modular construction may be somewhat 'blurred' in the case of the dystrophins. Electron-microscopic studies confirm that, as with the spectrins, the corresponding repeat region is responsible for conferring on dystrophin an extended rod-like shape approximately 110-170 nm in length. There is, however, no evidence for the antiparallel dimerization observed in both spectrins and α-actinins [22].

In the case of vertebrate dystrophins, approximately 24 repeats can be distinguished. The rod domain in the nematode dystrophin is almost identical in size, suggesting that interaction with some other agent places a tight constraint on length (indeed, some humans with interstitial in-frame deletion of a single repeat can suffer appreciable myopathy). Utrophin has a slightly shorter rod domain, with 22 repeats (the missing length is in the region of repeats 14 and 18 of dystrophin). The Drosophila dystrophin rod domain is even shorter than this, with the region corresponding to repeats 14-20 of human dystrophin being half the length. DRP2, like the 116 kDa Dp116 isoform of dystrophin, has a mere two repeats, with a unique 75-residue random-coiled amino terminus.

The cysteine-rich region (residues 3,056-3,354 of human dystrophin; residues 1-284 of human α-dystrobrevin)

At the end of the dystrophin rod domain is a highly conserved constellation of motifs that constitutes a key feature of the dystrophin/dystrobrevin family. The generally accepted name is something of a misnomer, as only five of the fifteen cysteines (in human dystrophin) that give the region its name are highly conserved, four of these being metal ligands in the ZZ domain (see below).

The region comprises the following domains in amino-to-carboxyl order. First, a WW domain [23], which is small (about 40 amino acids), composed largely of β sheet, and named after its two conserved tryptophan residues; it usually binds proline-rich motifs and is missing from dystrobrevin and DAH. Second, EF hands [24], which comprise hairpins of α helices, with the intervening turn often coordinating Ca2+. These are almost invariably duplicated to form a packed pair of hairpins; although only one such module was originally identified in the dystrophins, the recent crystal structure shows the existence of a second, giving a total of four hairpins. None of the loops appears to coordinate metal ions. Finally, a ZZ domain, which has been found in a wide range of proteins [25]. Its structure is reinforced by coordination of Zn2+ by cysteine side chains (four in the vertebrate dystrophins; six in the invertebrate dystrophins and the dystrobrevins), and its function is not known.

Functional studies show that the cysteine-rich domain mediates the interaction between dystrophin and the intracellular tail of β-dystroglycan, a transmembrane component of the dystrophin complex. This is probably the critical site of membrane attachment for dystrophin, and loss of this interaction results in a null phenotype. The structure of most of this region has recently been solved at the atomic level [26]. It turns out to be a rather compact entity, with the WW domain and the EF hands intimately packed (Figure 2). A co-crystal with a β-dystroglycan peptide reveals that the latter's PPPY motif binds the WW domain, with the remainder of the β-dystroglycan enjoying an extended interaction across one surface of the EF hands [26].

The carboxy-terminal region (residues 3,355-3,685 of human dystrophin; 285-686 of human (α-dystrobrevin)

After the ZZ domain is an α-helical region, which has been shown in both dystrophin and dystrobrevin to mediate the interaction with the carboxyl termini of members of the syntrophin family of cytoplasmic adapter proteins [27]. The syntrophin-binding segment is subject to complex patterns of alternative splicing in both dystrophins and dystrobrevins, suggesting that the stoichiometry of the complex can be modulated. This is followed by two sets of helical leucine-heptad motifs, which are responsible for the homotypic interaction between dystrophins and dystrobrevins [28].

The extreme carboxyl terminus differs markedly between dystrophin and dystrobrevin, and no function has been ascribed to this region. Alternative splicing can generate novel carboxyl termini: in the case of vertebrate dystrophin in non-muscle tissues, a 39-residue sequence homologous to the constitutive carboxyl terminus of invertebrate dystrophins is added; and in the case of α-dystrobrevin in the neuromuscular junction, a unique 188-residue domain is added that is subject to tyrosine phosphorylation.

The dystrophin carboxy-terminal region appears to be dispensable for normal muscle function, as shown by rescue of dystrophin-deficient mice by transgene expression and by certain rare human mutations ([29] and my unpublished observations).

Localization and function

Localization

All members of the dystrophin and dystrobrevin family appear to be membrane-associated. Vertebrate dystrophin is located at the cytoplasmic membrane of skeletal, cardiac and smooth muscle cells [30] and at a subset of synapses in the central nervous system [31]. Shorter forms of dystrophin, generated by alternative promoter usage, are variously expressed at retinal synapses (Dp260 [32]), at the outer surface of Schwann cells in the peripheral nervous system (Dp116 [33,34]), and more widely (Dp71 [35]). Utrophin is widely expressed throughout the body, with a striking concentration at the neuromuscular and myotendinous junctions [36] and at various specialized membranes in the brain [37]. DRP2 is found at a range of synapses throughout the central nervous system [38] and in Schwann cells in the peripheral nervous system (D.L. Sherman, C. Fabrizi, C.S. Gillespie and P.J. Brophy, personal communication). The localization of invertebrate dystrophins is known only for the nematode Caenorhabditis elegans Dys-1 protein, which seems to be mainly expressed in muscle cells [39], although the expression of Dyb-1 (see below) makes it likely that Dys-1 may be more widely expressed.

The dystrobrevins are less well studied, but appear to parallel the dystrophins in their expression, with α-dystrobrevin in muscle and the central nervous system and β-dystrobrevin predominant in the brain and other tissues, such as kidney and placenta. Muscle α-dystrobrevin, like dystrophin, is localized to the muscle plasma membrane (sarcolemma) [40]. Nematode dystrobrevin (Dyb-1) is expressed in most muscles and neurons [41].

Function

The fundamental role of the dystrophins and dystrobrevins remains unclear. Much of what we do know has been gleaned from biochemical studies of associated proteins and from the phenotypic consequences of their loss.

Dystrophin forms part of a complex (Figure 3) that includes both integral (dystroglycan, the sarcoglycans) and peripheral (dystrophin, dystrobrevin, the syntrophins) membrane proteins. Dystroglycan, whose direct interaction with dystrophin is described above, crosses the membrane and binds to agrin and laminin in the extracellular matrix [42]. The sarcoglycans form a separable heterotetrameric transmembrane sub-complex of unknown function [43]; this associates laterally with dystroglycan and sarcospan, and probably also directly with dystrophin and/or dystrobrevin [40,44]. The five syntrophins [45] are cytoplasmic adapter proteins containing plextrin-homology and PSD-95/SAP-90, discs large, ZO-1 (PDZ) domains, which bind directly to the carboxy-terminal region of dystrophin and dystrobrevin (see above), and also appear to bind neuronal nitric oxide synthase and voltage-gated Na+ channels via their PDZ domains [46,47]. A number of other proteins (including syncoilin, biglycan, filamin 2, and sarcospan) have been associated with the complex, but their significance is as yet less certain.
Figure 3

Schematic diagram of the dystrophin complex as found in vertebrate skeletal muscle, showing the currently understood relationships between the better characterized components. Dystrophin and dystrobrevin form the cytoplasmic core.

Important mutants

The consequences of null mutation are known for humans and/or rodents in the case of dystrophin, utrophin, and α-dystrobrevin, and for nematode in the case of dystrophin and dystrobrevin. The lack of dystrophin that underlies DMD results in secondary loss of all other components of the dystrophin complex from the membrane and ultimately leads to a lethal syndrome of skeletal and cardiac myopathy (involving cycles of membrane failure, cell death, failure to regenerate and fibrosis), stationary night blindness, mental retardation, a cardiac-conduction defect and a subtle smooth-muscle defect. Many of these traits are recapitulated in a subset of the limb-girdle muscular dystrophies that result from sarcoglycan defects [48]. The dystrophin-deficient mouse has a similar but milder phenotype, somewhat mitigated by partial complementation of the dystrophin deficiency by utrophin.

There is as yet no known human defect of utrophin, DRP2 or α-dystrobrevin. A mouse knockout of utrophin has an extremely subtle defect in the structure of its neuromuscular junctions; the importance of utrophin's role is revealed only in the double knockout of both dystrophin and utrophin genes, which has a severe myopathy and structural abnormalities of the neuromuscular junction [49,50]. A mouse α-dystrobrevin knockout displays a gross phenotype similar to that of a null dystrophin mutant, but the integrity of the complex is largely maintained [51]. The loss of both dystrophin and dystrobrevin in the nematode C. elegans results in a neuromuscular defect that seems to stem from a hypersensitivity to acetylcholine [52].

Frontiers

With the basic function of this substantial complex still eluding definition, the principal frontier of dystrophin and dystrobrevin research is self-evident. Considerations of the function of dystrophin dwell largely on two areas, namely a mechanical role and a signaling role. Mechanical models note the actin-dystrophin-dystroglycan-laminin axis, which suggests a mechanical link between the intracellular cytoskeleton and the extracellular matrix. Signaling models note the preponderance of circumstantial associations with molecules whose main role is in communication - for example, agrin, neuronal nitric oxide synthase, voltage-gated Na+ channels, and perhaps sarcoglycans. The two models are not mutually exclusive.

A common theme that seems to run through dystrophin biology is that of synaptic function. In vertebrates, dystrophin and DRP2 are localized to central synapses and utrophin to the neuromuscular junction, a specialized cholinergic synapse. The nematode mutants seem to imply a role for dystrophin and dystrobrevin in cholinergic transmission. Is the ancestral function of these proteins one of synaptic structural organization or regulation? If so, what are they doing in clearly non-synaptic places such as the sarcolemma? Investigation of dystrophins and from disparate organisms and in different tissues may shed light on these and other questions.

Authors’ Affiliations

(1)
Division of Medical and Molecular Genetics, Guy's, King's and St Thomas' Medical School, Guy's Hospital

References

  1. Koenig M, Monaco AP, Kunkel LM: The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988, 53: 219-226. Full primary structure of the protein defective in DMD.PubMedView ArticleGoogle Scholar
  2. Leiden Muscular Dystrophy Pages. Updated source of information on the muscular dystrophies, maintained at Leiden University., [http://www.dmd.nl/dmdhome.html]
  3. OMIM 310200. Online Mendelian Inheritance in Man (OMIM) entry for Duchenne and Becker muscular dystrophy., [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=310200]
  4. Love DR, Hill DF, Dickson G, Spurr NK, Byth BC, Marsden RF, Walsh FS, Edwards YH, Davies KE: An autosomal transcript in skeletal muscle with homology to dystrophin. Nature. 1989, 339: 55-58. 10.1038/339055a0. The first inkling that dystrophin belongs to an extended family.PubMedView ArticleGoogle Scholar
  5. Roberts RG, Freeman TC, Kendall E, Vetrie DL, Dixon AK, Shaw-Smith C, Bone Q, Bobrow M: Characterization of DRP2, a novel human dystrophin homologue. Nat Genet. 1996, 13: 223-226. The first description of DRP2, its gene and its expression.PubMedView ArticleGoogle Scholar
  6. Roberts RG, Bobrow M: Dystrophins in vertebrates and invertebrates. Hum Mol Genet. 1998, 7: 589-595. 10.1093/hmg/7.4.589. A broad assessment of the distribution of dystrophins in the animal kingdom - the first description of invertebrate dystrophins.PubMedView ArticleGoogle Scholar
  7. Wagner KR, Cohen JB, Huganir RL: The 87K postsynaptic membrane protein from Torpedo is a protein-tyrosine kinase substrate homologous to dystrophin. Neuron. 1993, 10: 511-522. Identification of Torpedo dystrobrevin as a cholinergic synaptic protein.PubMedView ArticleGoogle Scholar
  8. Sadoulet-Puccio HM, Khurana TS, Cohen JB, Kunkel LM: Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane. Hum Mol Genet. 1996, 5: 489-496. 10.1093/hmg/5.4.489. Description of human α-dystrobrevin, including its complex alternative splicing and tissue distribution.PubMedView ArticleGoogle Scholar
  9. Blake DJ, Nawrotzki R, Loh NY, Gorecki DC, Davies KE: β-dystrobrevin, a member of the dystrophin-related protein family. Proc Natl Acad Sci USA. 1998, 95: 241-246. 10.1073/pnas.95.1.241. The discovery that vertebrates have two dystrobrevins.PubMedPubMed CentralView ArticleGoogle Scholar
  10. Peters MF, O'Brien KF, Sadoulet-Puccio HM, Kunkel LM, Adams ME, Froehner SC: β-dystrobrevin, a new member of the dystrophin family. Identification, cloning, and protein associations. J Biol Chem. 1997, 272: 31561-31569. 10.1074/jbc.272.50.31561. The discovery that vertebrates have two dystrobrevins.PubMedView ArticleGoogle Scholar
  11. Sadoulet-Puccio HM, Feener CA, Schaid DJ, Thibodeau SN, Michels VV, Kunkel LM: The genomic organization of human dystrobrevin. Neurogenetics. 1997, 1: 37-42. 10.1007/s100480050006. An assessment of gene structure conservation in the dystrobrevins (and dystrophins).PubMedView ArticleGoogle Scholar
  12. Zhang CX, Lee MP, Chen AD, Brown SD, Hsieh T: Isolation and characterization of a Drosophila gene essential for early embryonic development and formation of cortical cleavage furrows. J Cell Biol. 1996, 134: 923-934. Description of DAH and the effects of its deficiency in the fruit fly.PubMedView ArticleGoogle Scholar
  13. Greener MJ, Roberts RG: Conservation of components of the dystrophin complex in Drosophila. FEBS Lett. 2000, 482: 13-18. 10.1016/S0014-5793(00)02018-4. Demonstration that all core components of the dystrophin complex, together with their interacting motifs, are conserved in an invertebrate.PubMedView ArticleGoogle Scholar
  14. Roberts RG, Coffey AJ, Bobrow M, Bentley DR: Exon structure of the human dystrophin gene. Genomics. 1993, 16: 536-538. 10.1006/geno.1993.1225. The massive human dystrophin gene is established as having 79 coding exons.PubMedView ArticleGoogle Scholar
  15. Feener CA, Koenig M, Kunkel LM: Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature. 1989, 338: 509-511. 10.1038/338509a0. Complex but reproducible alternative splicing, particularly in the syntrophin-binding region, adds to the complexity of the dystrophin protein.PubMedView ArticleGoogle Scholar
  16. Bies RD, Phelps SF, Cortez MD, Roberts R, Caskey CT, Chamberlain JS: Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development. Nucleic Acids Res. 1992, 20: 1725-1731. Further study of dystrophin alternative splicing, including its robust conservation in another mammal.PubMedPubMed CentralView ArticleGoogle Scholar
  17. Roberts Lab Homepage. Updated sequence alignment of all known components of the dystrophin complex., [http://www.kcl.ac.uk/ip/ebitimiigbaseimokumo/molecularneuroscience.html]
  18. Holland PW, Garcia-Fernandez J, Williams NA, Sidow A: Gene duplications and the origins of vertebrate development. Development. 1994, Suppl: 125-133. Observation that multiple duplications in many vertebrate gene families since our divergence from amphioxus may hint at whole-genome duplication.Google Scholar
  19. Norwood FL, Sutherland-Smith AJ, Keep NH, Kendrick-Jones J: The structure of the N-terminal actin-binding domain of human dystrophin and how mutations in this domain may cause Duchenne or Becker muscular dystrophy. Structure Fold Des. 2000, 8: 481-491. 10.1016/S0969-2126(00)00132-5. Crystal structure of the actin-binding domain of dystrophin.PubMedView ArticleGoogle Scholar
  20. Moores CA, Keep NH, Kendrick-Jones J: Structure of the utrophin actin-binding domain bound to F-actin reveals binding by an induced fit mechanism. J Mol Biol. 2000, 297: 465-480. 10.1006/jmbi.2000.3583. Modeling of the utrophin actin-binding domain onto low-resolution structures of decorated actin fibers.PubMedView ArticleGoogle Scholar
  21. Winder SJ, Gibson TJ, Kendrick-Jones J: Dystrophin and utrophin: the missing links!. FEBS Lett. 1995, 369: 27-33. 10.1016/0014-5793(95)00398-S. An early reviewof dystrophin structure, including a detailed analysis of the rod domain.PubMedView ArticleGoogle Scholar
  22. Chan Y, Kunkel LM: In vitro expressed dystrophin fragments do not associate with each other. FEBS Lett. 1997, 410: 153-159. 10.1016/S0014-5793(97)00454-7. Demonstration that the dystrophin rod domain does not share an important property of the spectrin rod.PubMedView ArticleGoogle Scholar
  23. Bork Lab WW domain Page. Well-maintained website devoted to the WW domain., [http://www.bork.embl-heidelberg.de/Modules/ww/]
  24. Structural Classification of Proteins: EF-hand Superfamily. The SCOP page that defines the EF hand., [http://www.beri.co.jp/scop/data/scop.1.001.041.001.html]
  25. Ponting CP, Blake DJ, Davies KE, Kendrick-Jones J, Winder SJ: ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins. Trends Biochem Sci. 1996, 21: 11-13. 10.1016/0968-0004(96)80878-4. Identification of the ZZ domain as a widespread protein motif.PubMedView ArticleGoogle Scholar
  26. Huang X, Poy F, Zhang R, Joachimiak A, Sudol M, Eck MJ: Structure of a WW domain containing fragment of dystrophin in complex with β-dystroglycan. Nat Struct Biol. 2000, 7: 634-638. 10.1038/77923. Crystal structure of much of the 'cysteine-rich' region from dystrophin with a bound dystroglycan peptide.PubMedView ArticleGoogle Scholar
  27. Ahn AH, Kunkel LM: Syntrophin binds to an alternatively spliced exon of dystrophin. J Cell Biol. 1995, 128: 363-371. Location of the precise site of interaction of the syntrophins on dystrophin.PubMedView ArticleGoogle Scholar
  28. Sadoulet-Puccio HM, Rajala M, Kunkel LM: Dystrobrevin and dystrophin: an interaction through coiled-coil motifs. Proc Natl Acad Sci USA. 1997, 94: 12413-12418. 10.1073/pnas.94.23.12413. Characterization of the site of interaction of dystrophin and α-dystrobrevin.PubMedPubMed CentralView ArticleGoogle Scholar
  29. Crawford GE, Faulkner JA, Crosbie RH, Campbell KP, Froehner SC, Chamberlain JS: Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain. J Cell Biol. 2000, 150: 1399-1410. 10.1083/jcb.150.6.1399. Rescue of dystrophin-deficient mice with truncated transgenes reveals the functional importance of regions of the dystrophin protein.PubMedPubMed CentralView ArticleGoogle Scholar
  30. Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AH, Belfall B, Klamut HJ, Talbot J, Hodges RS, Ray PN, Worton RG: The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature. 1988, 333: 466-469. 10.1038/333466a0. The first description of the subcellular localization of dystrophin in muscle.PubMedView ArticleGoogle Scholar
  31. Lidov HG, Byers TJ, Watkins SC, Kunkel LM: Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature. 1990, 348: 725-728. 10.1038/348725a0. The first suggestion of a synaptic role for a dystrophin.PubMedView ArticleGoogle Scholar
  32. D'Souza VN, Nguyen TM, Morris GE, Karges W, Pillers DA, Ray PN: A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet. 1995, 4: 837-842. Elucidation of the basis of the electroretinopathy of some DMD patients (Dp260).PubMedView ArticleGoogle Scholar
  33. Byers TJ, Lidov HG, Kunkel LM: An alternative dystrophin transcript specific to peripheral nerve. Nat Genet. 1993, 4: 77-81. Discovery of the dystrophin Dp116 isoform.PubMedView ArticleGoogle Scholar
  34. Matsumura K, Yamada H, Shimizu T, Campbell KP: Differential expression of dystrophin, utrophin and dystrophin-associated proteins in peripheral nerve. FEBS Lett. 1993, 334: 281-285. 10.1016/0014-5793(93)80695-Q. Further studies of Dp116 and its associated proteins, building the picture of an unknown role in peripheral nerve.PubMedView ArticleGoogle Scholar
  35. Rapaport D, Lederfein D, den Dunnen JT, Grootscholten PM, Van Ommen GJ, Fuchs O, Nudel U, Yaffe D: Characterization and cell type distribution of a novel, major transcript of the Duchenne muscular dystrophy gene. Differentiation. 1992, 49: 187-193. Identification of the widely expressed Dp71 dystrophin isoform.PubMedView ArticleGoogle Scholar
  36. Khurana TS, Watkins SC, Chafey P, Chelly J, Tome FM, Fardeau M, Kaplan JC, Kunkel LM: Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord. 1991, 1: 185-194. 10.1016/0960-8966(91)90023-L. Demonstration that utrophin is localized to the neuromuscular and myotendinous junctions in muscle.PubMedView ArticleGoogle Scholar
  37. Khurana TS, Watkins SC, Kunkel LM: The subcellular distribution of chromosome 6-encoded dystrophin-related protein in the brain. J Cell Biol. 1992, 119: 357-366. Description of the presence of utrophin in brain membrane structures.PubMedView ArticleGoogle Scholar
  38. Roberts RG, Sheng M: Association of dystrophin-related protein 2 (DRP2) with postsynaptic densities in rat brain. Mol Cell Neurosci. 2000, 16: 674-685. 10.1006/mcne.2000.0895. Subcellular localization of DRP2 protein in the brain.PubMedView ArticleGoogle Scholar
  39. Bessou C, Giugia JB, Franks CJ, Holden-Dye L, Segalat L: Mutations in the Caenorhabditis elegans dystrophin-like gene dys-1 lead to hyperactivity and suggest a link with cholinergic transmission. Neurogenetics. 1998, 2: 61-72. 10.1007/s100480050053. The phenotypic consequences of dystrophin mutation in an invertebrate.PubMedView ArticleGoogle Scholar
  40. Metzinger L, Blake DJ, Squier MV, Anderson LV, Deconinck AE, Nawrotzki R, Hilton-Jones D, Davies KE: Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy. Hum Mol Genet. 1997, 6: 1185-1191. 10.1093/hmg/6.7.1185. Subcellular localization of α-dystrobrevin in muscle, and its dependence on dystrophin.PubMedView ArticleGoogle Scholar
  41. Gieseler K, Mariol MC, Bessou C, Migaud M, Franks CJ, Holden-Dye L, Segalat L: Molecular, genetic and physiological characterisation of dystrobrevin-like (dyb-1) mutants of Caenorhabditis elegans. J Mol Biol. 2001, 307: 107-117. 10.1006/jmbi.2000.4480. The phenotypic consequences of dystrobrevin deficiency in an invertebrate.PubMedView ArticleGoogle Scholar
  42. Winder SJ: The complexities of dystroglycan. Trends Biochem Sci. 2001, 26: 118-124. 10.1016/S0968-0004(00)01731-X. An up-to-date review of the many aspects of dystroglycan biology.PubMedView ArticleGoogle Scholar
  43. Yoshida M, Suzuki A, Yamamoto H, Noguchi S, Mizuno Y, Ozawa E: Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl β-D-glucoside. Eur J Biochem. 1994, 222: 1055-1061. Separation of the sarcoglycan complex as a distinct entity.PubMedView ArticleGoogle Scholar
  44. Yoshida M, Hama H, Ishikawa-Sakurai M, Imamura M, Mizuno Y, Araishi K, Wakabayashi-Takai E, Noguchi S, Sasaoka T, Ozawa E: Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. Hum Mol Genet. 2000, 9: 1033-1040. 10.1093/hmg/9.7.1033. Suggests a direct interaction between dystrobrevin and the sarcoglycans.PubMedView ArticleGoogle Scholar
  45. Piluso G, Mirabella M, Ricci E, Belsito A, Abbondanza C, Servidei S, Puca AA, Tonali P, Puca GA, Nigro V: γ1- and γ2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells. J Biol Chem. 2000, 275: 15851-15860. 10.1074/jbc.M000439200. The discovery of two novel syntrophins brings the vertebrate complement up to five.PubMedView ArticleGoogle Scholar
  46. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, Huang F, Xia H, Peters MF, et al: Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell. 1996, 84: 757-767. Neuronal nitric oxide synthase is brought into the dystrophin story.PubMedView ArticleGoogle Scholar
  47. Gee SH, Madhavan R, Levinson SR, Caldwell JH, Sealock R, Froehner SC: Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins. J Neurosci. 1998, 18: 128-137. Report of the interaction between syntrophins and membrane-bound sodium channels.PubMedGoogle Scholar
  48. Bushby KM: The limb-girdle muscular dystrophies - multiple genes, multiple mechanisms. Hum Mol Genet. 1999, 8: 1875-1882. 10.1093/hmg/8.10.1875. A review of the phenotypes and molecular etiologies of the limb-girdle muscular dystrophies, including the sarcoglycanopathies.PubMedView ArticleGoogle Scholar
  49. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, Watt DJ, Dickson JG, Tinsley JM, Davies KE: Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell. 1997, 90: 717-727. Shows that mice lacking both dystrophin and utrophin have a severe phenotype.PubMedView ArticleGoogle Scholar
  50. Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, Sanes JR: Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell. 1997, 90: 729-738. Shows that mice lacking both dystrophin and utrophin have a severe phenotype.PubMedView ArticleGoogle Scholar
  51. Grady RM, Grange RW, Lau KS, Maimone MM, Nichol MC, Stull JT, Sanes JR: Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol. 1999, 1: 215-220. 10.1038/12034. Targeted disruption of the α-dystrobrevin gene in mice results in a myopathic phenotype.PubMedView ArticleGoogle Scholar
  52. Gieseler K, Bessou C, Segalat L: Dystrobrevin- and dystrophin-like mutants display similar phenotypes in the nematode Caenorhabditis elegans. Neurogenetics. 1999, 2: 87-90. 10.1007/s100480050057. Demonstrates that dystrophin and dystrobrevin mutations in nematode act via the same mechanism.PubMedView ArticleGoogle Scholar

Copyright

© BioMed Central Ltd 2001